Sentence examples for injection vials from inspiring English sources

The dried extracts were reconstituted with 0.50 mL of the mobile phase solution of ammonium bicarbonate (5 mM) pH 7.8 – acetonitrile (1 1 v/v) in injection vials and later injected in LC-QqQMS or LC-QqToFMS for analysis.

The contents of two injection vials, each having an amount equivalent to 30 mg of active ingredient was filtered through Whatmann No. 40 filter paper and transferred into two separate 100-mL calibrated flask.

Small (~10 mL) flat bottomed, clear, glass injection vials (so called headspace vials, ~22 mm outer diameter, ~40 mm height) with wide opening (see for example J.G. Finneran Associates, Inc., 310020-2346) whicancan be tightly stoppered.

Several assay methods have been based on headspace solid-phase micro extraction (HS-SPME) [14, 15, 22, 28], where the headspace is discriminatory in nature because only the volatile compounds in the injection vials can be transferred to the GC system.

Inlet liners and injection vials were deactivated using a solution of 5%% dichlorodimethylsilane in toluene.

Thirteen samples were not consistent with the genuine comparator when analyzed with the CD-3, including five oral artesunate blisters, five chloroquine injection vials, and three quinine injection vials.

An aliquot (about 300 μL) of the supernatant was filtered through a 0.2-μm filter column and transferred into an HPLC sample injection vial, and an aliquot of 50 μL of the extract was injected into an HPLC system equipped with a C18 reversed-phase column and an ESA Coulochem II electrochemical detector (ESA, Inc., Chelmsford, MA, USA).

CP was obtained in the form of powder (Endoxan injection vial) manufactured by Baxter Oncology, Germany.

Supernatant was filtered through a 0.2 μm filter directly to injection vial prior to LC-MS/MS analysis.

This case report describes the identification of His-tagged Long-R3-IGF-I, which is usually produced for biochemical studies, in an injection vial.

The most discriminating conditions were obtained when shaking of the formulations was performed at 200 rpm in a 2 ml injection vial filled with 1 ml protein solution.